Positions

Assistant Professor and Director, Surgical Innovation and Technology Development
Department of Surgery
Baylor College of Medicine
Adjunct Assistant Professor
Biomedical Engineering
University of Houston
Adjunct Associate Professor
Swansea University School of Medicine
Adjunct Assistant Professor
Department of Bioengineering
Rice University

Education

PhD from Dublin City University
MEng from Dublin City University
BEng from University of Glasgow

Professional Interests

  • Nanomedicine
  • Non-invasive radiofrequency hyperthermia
  • Surgical Technology
  • Nanomaterials characterization

Professional Statement

Dr. Corr obtained his BEng (hons) in Electronics with Music from The University of Glasgow, He went on to study an MEng in Electrical Systems majoring in nanoelectronics and photonics at Dublin City University, Rep. of Ireland. During this period, he was selected for the Irish Government sponsored FÁS Science Challenge, which placed him in Dr. Lon J. Wilson's Nano-materials group at Rice University, Department of Chemistry where he worked on building a prototype to quantify cyclic magnetic field absorption by gadolinium loaded ultrashort carbon nanotubes (Gd3+ US-SWNTs), which are used as superlative MRI contrast agents.

Having returned to Dublin to finish his masters he then completed his Ph.D. studies, over a period of two years, in the field of silver nanoparticles and thin-films for surface enhanced Raman spectroscopy of strained silicon. He subsequently spent a 3-month period at the International Space University, Strasbourg, France, as part of their MSc. in Space Studies program - a program which he is still affiliated with. With this knowledge and experience he was asked to return to Rice as a postdoctoral fellow, to synthesize and apply silver nanoparticles to non-invasive radio frequency (RF) hyperthermia, which was part of an active collaboration between Prof Wilson and Dr. Steven A. Curley, at MD Anderson Cancer Center. Since working on this project in 2009, Dr. Corr eventually transferred over to MDACC in 2011 and has since been involved in the research and development of nanoparticle-assisted non-invasive RF hyperthermia.

RF technology is gaining prominence as a powerful new surgical oncology tool in the fight against cancer. Recent work has shown synergy when combining RF therapy with systemic chemotherapy administration.

Our current studies have also shown enhanced delivery and retention of chemotherapeutics into tumors when exposed to low levels of RF fields. I am currently active in this field and we are currently seeking FDA approval for full human trials.

Selected Publications